mesenteric ischaemia

in review 5 min read Updated 2026-11-19
mesenteric ischaemia

Severe abdominal pain out of proportion to the examination = acute mesenteric ischaemia until proven otherwise, especially with AF, recent MI, vascular disease, or a shocked ICU patient on vasopressors. Ischaemia starts in the mucosa, so pain comes hours before peritonism. CTA without delay — no lab test rules it in or out, and a normal lactate doesn’t reassure. Treat at once: fluids, broad-spectrum antibiotics, IV heparin, then revascularise (often endovascular first) or explore if peritonitic. Mortality 30–70%, driven by delay.


suspect it early: the exam lags the bowel

Mucosa infarcts first, serosa last → excruciating pain with a soft abdomen early. Peritonism means transmural necrosis has already happened.

TypeShareSettingClue
arterial embolism (SMA)~25–50%atrial fibrillation, recent MI, LV thrombus, endocarditissudden severe pain, often other emboli, gut emptying (vomiting, diarrhoea)
arterial thrombosis~20–40%atherosclerosis, prior chronic mesenteric ischaemiaweeks–months of postprandial pain, food fear, weight loss → acute on chronic
non-occlusive (NOMI)~15–25%shock, high-dose vasopressors, HF, after cardiac surgery or arrest, dialysisICU patient with distension, GI bleeding, rising lactate; pain may be absent (sedated)
mesenteric venous thrombosis5–15%prothrombotic state, cirrhosis/portal hypertension, cancer, pancreatitissubacute cramping, nausea, diarrhoea; GI bleeding in ~10%

Acute-on-chronic thrombotic presentations are becoming commoner than the classic embolic one. Right-sided pain with maroon or bloody stool in a low-flow patient → think NOMI or right-sided colonic ischaemia → lower GI bleeding.


investigations: CTA, not lactate

do not delay CTA for renal function or a normal lactate

Each 6 h of delay to CTA roughly doubles mortality. Order arterial + portal venous phase CTA immediately regardless of eGFR (ESVS), and write “?mesenteric ischaemia” on the request so protocol and read match. A normal lactate does not exclude ischaemia.

  • CTA diagnoses arterial occlusion, venous thrombosis and signs of infarction (pneumatosis, portal venous gas, non-enhancing bowel)
  • no lab test is accurate enough. WBC is raised in >90% and lactate in ~90%, but both are non-specific and late; a high lactate may just be dehydration. D-dimer may support it, but a single lactate or D-dimer should never be used to confirm or exclude the diagnosis (ESVS)
  • plain abdominal X-ray → not useful; normal early
  • ECG/echo for an embolic source once stable

management

On diagnosis: IV fluids, correct electrolytes, NG decompression, broad-spectrum antibiotics now (enteric + anaerobic per local protocol — ESVS I, Level C), IV UFH (titratable/reversible before OR or endovascular), and vascular + general surgery together. Outcomes are best at centres with a multidisciplinary pathway.

arterial (embolus or thrombosis)

flowchart LR
  A["acute arterial SMA occlusion"] --> B{"peritonitis?"}
  B -->|"yes"| C["laparotomy / laparoscopy\nrevascularise first → resect only dead bowel\nplanned second look 24–48 h"]
  B -->|"no"| D["endovascular first-line\n(aspiration / lysis / stent)"]
  D --> E["laparoscopy if bowel\nviability in doubt"]
  • peritonitis → laparotomy/laparoscopy, revascularise, resect only clearly dead bowel; planned second look at 24–48 h, especially with extensive involvement or if not improving (damage-control surgery, temporary closure). Post-op ICU: perfusion-directed support, continue antibiotics and heparin
  • no peritonitis → endovascular revascularisation first-line where expertise exists (aspiration/thrombolysis, stent; observational data — no RCTs), then laparoscopy if bowel viability is in doubt
  • revascularise before resecting bowel where possible (ESVS IIa) — restored flow saves bowel that looked dead
  • after revascularisation → surveillance imaging and long-term antithrombotic therapy:
    • embolic → anticoagulate (DOAC or VKA once recovered)
    • stented → antiplatelet; DAPT for at least 1 month may be considered (ESVS IIb, consensus only)

non-occlusive mesenteric ischaemia (NOMI)

  • suspect in a shocked patient whose CTA shows poorly enhancing or thickened bowel, pneumatosis or portal venous gas without an SMA occlusion
  • treat the cause: restore perfusion and cardiac output with fluids and the vasoactive support actually needed; avoid excess vasoconstriction (WSES advises minimising vasopressors)
  • heparin may be considered if not bleeding; intra-arterial vasodilator (papaverine) into the SMA in specialist centres
  • abdominal compartment syndrome → urgent decompression laparotomy
  • peritonitis, perforation or deterioration → surgery; infarcted bowel → resect promptly

mesenteric venous thrombosis

  • anticoagulation is the treatment: UFH or LMWH at diagnosis
  • continue for 3–6 months in all with VKA or LMWH; a DOAC is an acceptable alternative (weaker evidence)
  • indefinitely if idiopathic or a permanent risk factor; consider extending beyond 6 months even with transient risk factors (ESVS IIa) → VTE anticoagulation
  • look for the cause: intra-abdominal cancer or inflammation, cirrhosis, myeloproliferative neoplasm, CMV/COVID; antiphospholipid testing if recurrent MVT or recurrent pregnancy loss
  • surgery only for peritonitis, resecting only necrotic bowel (heparin often improves the picture over 24–48 h); deteriorating on anticoagulation → catheter-directed lysis or thrombectomy

palliation and recovery

  • massive necrosis in a frail patient → goals-of-care conversation; palliation is a legitimate choice → goals of care
  • survivors of extensive resection → short bowel syndrome → nutrition team

chronic mesenteric ischaemia

Postprandial pain, food fear, weight loss (± diarrhoea) in an arteriopath. Collaterals protect against single-vessel disease, so symptoms usually need multivessel disease. Matters because these patients can progress to acute thrombosis.

  • diagnosis: chronic symptoms + >50% SMA stenosis and >50% in another mesenteric artery. Isolated >70% SMA stenosis may be enough (ESVS IIb). Other causes of weight loss and pain still need excluding
  • fasting mesenteric duplex first, CTA to confirm and plan; refer to a specialised centre
  • revascularise symptomatic patients (at least the SMA) → endovascular stenting first (stent, not balloon angioplasty alone); open bypass if stenting fails or isn’t feasible in a fit patient. Severe CMI (marked weight loss, constant pain) → don’t delay revascularisation to build up nutrition
  • asymptomatic stenosis found incidentally → prophylactic revascularisation rarely (only highly selected multivessel disease). Give secondary prevention (statin, antiplatelet) and tell the patient which symptoms to report
  • follow-up: clinical and imaging review in the first year after revascularisation; duplex for recurrent symptoms; symptomatic restenosis → endovascular retreatment

Prepared 2026-11-19. Not yet verified — check every number against the sources.

Key references

Suggest a correction mesenteric ischaemia